Acute heparin-induced thrombocytopenia type II during cardiopulmonary bypass

被引：0
|
作者：
Koster, A
Crystal, GJ
Kuppe, H
Mertzlufft, F
机构：
[1] Illinois Masonic Med Ctr, Dept Anesthesiol, Chicago, IL 60657 USA
[2] German Heart Inst Berlin, Dept Anesthesia, Berlin, Germany
[3] Univ Illinois, Coll Med, Dept Anesthesiol, Chicago, IL 60680 USA
[4] Univ Illinois, Coll Med, Dept Physiol & Biophys, Chicago, IL 60680 USA
[5] Univ Hosp, Dept Anesthesiol & Crit Care Med, Homburg, Germany
来源：
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA | 2000年 / 14卷 / 03期
关键词：
white clots; recombinant hirudin; ecarin clotting time; protamine;
D O I：
暂无
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
引用
收藏
页码：300 / 303
页数：4
相关论文
共 50 条
  • [41] Recognition and management of heparin-induced thrombocytopenia in pediatric cardiopulmonary bypass patients
    Boshkov, Lynn K.
    Kirby, Aileen
    Shen, Irving
    Ungerleider, Ross M.
    ANNALS OF THORACIC SURGERY, 2006, 81 (06): : S2355 - S2359
  • [42] Lepirudin for cardiopulmonary bypass surgery in a patient with terminal renal insufficiency and acute heparin-induced thrombocytopenia
    Riess, FC
    Dobritzsch, B
    Kormann, J
    THORACIC AND CARDIOVASCULAR SURGEON, 2006, 54 (02): : 140 - 142
  • [43] Cardiopulmonary bypass for heparin-induced thrombocytopenia: Management with a heparin-bonded circuit and enoxaparin
    Ganjoo, AK
    Harloff, MG
    Johnson, WD
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1996, 112 (05): : 1390 - 1392
  • [44] Bleeding complications associated with r-hirudin application for cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II
    Koster, A
    Kuppe, H
    Hetzer, R
    Mertzlufft, F
    ANESTHESIA AND ANALGESIA, 1999, 88 (04): : U8 - U8
  • [45] Cardiovascular surgery without cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II using anticoagulation with recombinant hirudin
    Koster, A
    Kuppe, H
    Crystal, GJ
    Mertzlufft, F
    ANESTHESIA AND ANALGESIA, 2000, 90 (02): : 292 - 298
  • [46] Cardiopulmonary bypass with recombinant hi-rudin in patients with heparin-induced thrombocytopenia type II: a synopsis of 19 cases
    Koster, A
    Kuppe, H
    Mertzlufft, F
    BRITISH JOURNAL OF ANAESTHESIA, 1999, 82 : 35 - 35
  • [47] One-year experience with the platelet glycoprotein IIb/IIIa antagonist tirofiban and heparin during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II
    Koster, A
    Meyer, O
    Fischer, T
    Kukucka, M
    Krabatsch, T
    Bauer, M
    Kuppe, H
    Hetzer, R
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2001, 122 (06): : 1254 - 1255
  • [48] The Perfect Match: A Combination of Cangrelor and Heparin for Heparin-Induced Thrombocytopenia during Cardiopulmonary Bypass in Heart and Kidney Transplant
    Kabra, N.
    McLenon, M.
    Gernhofer, Y.
    Mariski, M.
    Pretorius, V.
    Tran, H.
    Cronin, B.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (04): : S496 - S497
  • [49] Heparin-Induced Thrombocytopenia Type II Because of Heparin-Coated Polytetrafluoroethylene Graft Used to Bypass
    Gabrielli, Roberto
    Siani, Andrea
    Rosati, Maria Sofia
    Antonelli, Roberto
    Accrocca, Federico
    Giordano, Gioacchino Alessandro
    Marcucci, Giustino
    ANNALS OF VASCULAR SURGERY, 2011, 25 (06) : 840.e9 - 840.e12
  • [50] The Use of Bivalirudin for Cardiopulmonary Bypass Anticoagulation in Pediatric Heparin-Induced Thrombocytopenia Patients
    Gates, Richard
    Yost, Paul
    Parker, Beth
    ARTIFICIAL ORGANS, 2010, 34 (08) : 667 - U2
12345